Method of preparing pharmaceutical compositions

Details Method of preparing pharmaceutical compositions Method of preparing pharmaceutical compositions

2007-10-16

2007-10-16

Gitomer, Ralph (Department: 1657)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S018000, C435S069200

Reexamination Certificate

active

10785043

ABSTRACT:
A method for the discovery of compounds suitable for the treatment and/or prophylaxis of obesity, in which the ability of the test compounds to inhibit de novo lipogenesis in mammals and/or man is determined. The use of compounds which are capable of inhibiting de novo lipogenesis in mammals, and which are substantially free of effects directed towards the CNS, for the preparation of pharmaceutical compositions for the treatment and/or prophylaxis of obesity, as well as for the treatment and/or inhibition of obesity, are also described.

REFERENCES:
patent: 5597797 (1997-01-01), Clark
patent: 6288095 (2001-09-01), Hindley et al.
patent: 6946243 (2005-09-01), Hebebrand et al.
patent: 2003/0100594 (2003-05-01), Masferrer et al.
patent: 0138441 (1985-04-01), None
patent: WO-94/09813 (1994-05-01), None
patent: WO 98/00130 (1998-01-01), None
patent: WO9800130 (1998-01-01), None
Dulloo A. et al. Screening of Drugs for Thermogenic Anti-Obesity Properties: Antidepressants. Ann Nutr Metab 31(2)69-80, 1987.
Hazen, S. Differentiation Dependent Expression of CA V and the Role of Carbonic Anydrase Isozymes in Pyruvate Carboxylation in Adipocytes. FASEB J 1006, 10(4)481-490.
Karl M. Wilbur, “Electrometric and Colorimetric Determination of Carbonic Anhydrase” Journal of Biological Chemistry vol. 176, 1948.
Claudia T. Supuran, “Carbonic anhydrase inhibitors and their therapeutic potential” Ashley Publications Ltd., pp. 1354-3776, 2000.
MK Hellerstein, “De novo lipogenesis in humans: metabolic and regulatory aspects” European Journal of Clinical Nutrition, 1993.
Bruce E. Maryanoff, “Structure-Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhance Potency with Cyclic Sulfate Derivatives” J. Med. Chemistry, vol. 41, pp. 1315-1343, 1998.
Susanna J. Dodgson, “Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes” Epilepsia, vol. 41, 2000.
Y. Pocker, J.T. Stone, “The Catalytic Versatility of Erythrocyte Carbonic Anhydrase. The Enzyme-Catalyzed Hydrolysis of ρ-Nitrophenyl Acetate” Journal of the American Chemistry Society, 87:23, 1965.
Robert W. Heck, “Catalytic Properties of Mouse Carbonic Anhydrase V*” The Journal of Biological Chemistry, vol. 269, No. 40, 1994.
Claudiu T. Supuran, et al., “Carbonic anhydrase inhibitors and their therapeutic potential” Expert Opinion on Therapeutic Patents, 2000.
M. K. Hellerstein, et al., “De novo lipogenesis in humans: metabolic and regulatory aspects” European Journal of Cliinical Nutrition, 1999.
Gautam Sanyal, “Thermodynamics of Carbonic Amhydrase Catalysis” The Journal of Biological Chemistry, vol. 256, No. 2, 1981.
James E. P. Toman, “Properties of Maximal Seizures, and their Alteration by Anticonvulsant Drugs and other Agents” University of Utah School of Medicine, 1946.
Y. Pocker, “The Catalytic Versatility of Erythrocyte Carbonic Anhydrase III. Kinetic Studies of the Enzyme-Catalyzed Hydrolysis of ρ-Nitrophenyl Actate” Biochemistry, vol. 6, No. 3, 1967.
Claudia T. Supuran, “Carbonic anhydrase inhibitors-Part 53. Synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: The first non-polymeric membrane-impermeable inhibitors with selectivity for isozyme IV” Eur. J. Med. Chemistry, vol. 33, 1998.
Graham Chen, “Evaluation of Five Methods for Testing Anticonvulsant Activities” Department of Pharmacology, Parks, Davis & Co., 1954.
Andrea Scozzafava, “Carbonic Anhydrase Inhibitors: Synthesis of Water-Soluble, Aminoacyl/Dipeptidyl Sulfonamides Possessing Long-Lasting Intraocular Pressure-Lowering Properties via the Topical Route” J. Med. Chemistry, vol. 42, 1992.
Raja G. Khalifah, “The Carbon Dioxide Hydration Activity of Carbonic Anhydrase” The Journal of Biological Chemistry, vol. 246, No. 8, 1971.
Stacy A. Hazen, “Differentiation-dependent expression of CA V and the role of carbonic anhydrase isozymes in pyruvate carboxylation in adipocytes” The FASEB Journal, 1995.
Bruce E. Maryanoff, “Anticonvulsant O-Alkyl Sulfamates. 2,3:4,5-Bis-O- (1-methylethylidene) -B-D-fructopyranose Sulfamate and Related Compounds” American Chemistry Society, 1987.

Affiliated with

Also associated with

Rating

Method of preparing pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preparing pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3873026